Matches in Wikidata for { <http://www.wikidata.org/entity/Q95643417> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q95643417 description "article scientifique publié en 2020" @default.
- Q95643417 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95643417 description "scientific article published on 20 May 2020" @default.
- Q95643417 description "wetenschappelijk artikel" @default.
- Q95643417 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95643417 name "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 name "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 type Item @default.
- Q95643417 label "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 label "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 prefLabel "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 prefLabel "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 P1433 Q95643417-02A2A849-F618-469E-B8A4-43D155C1338E @default.
- Q95643417 P1476 Q95643417-F2E41D4D-E30E-49C6-8B27-521D8DECB62C @default.
- Q95643417 P2093 Q95643417-3FB37FE4-FB9B-4FCA-AE9A-F1D7F31B4700 @default.
- Q95643417 P2093 Q95643417-6EEC45BF-34CD-4F7B-9A64-0176ECB47FAE @default.
- Q95643417 P2093 Q95643417-7436185B-B1F3-4EAE-A5A1-8CE577F30702 @default.
- Q95643417 P2093 Q95643417-8DD5AFC6-0205-4B90-AF02-48D17B640910 @default.
- Q95643417 P2093 Q95643417-DA2E1117-B9F4-49D2-9593-BD89CFA55EAC @default.
- Q95643417 P304 Q95643417-40000607-D825-400D-84A4-B58F39530C22 @default.
- Q95643417 P31 Q95643417-CF1DAE00-9B7A-4D38-850E-567B926B963D @default.
- Q95643417 P356 Q95643417-DEB5E852-099A-4EF6-A32D-BCAD7AC3C042 @default.
- Q95643417 P577 Q95643417-03C7D0B3-3FB2-42CC-A8E2-651A5FFBBBAE @default.
- Q95643417 P698 Q95643417-3A22B1D2-A7EA-4927-B8B2-D152DF2C815C @default.
- Q95643417 P932 Q95643417-7A382157-265F-4805-846E-89B8FF4895CB @default.
- Q95643417 P356 J.NEUROPHARM.2020.108135 @default.
- Q95643417 P698 32445639 @default.
- Q95643417 P1433 Q15332439 @default.
- Q95643417 P1476 "Optopharmacology reveals a differential contribution of native GABAA receptors to dendritic and somatic inhibition using azogabazine" @default.
- Q95643417 P2093 "Arun P Pandurangan" @default.
- Q95643417 P2093 "James R Baker" @default.
- Q95643417 P2093 "Martin Mortensen" @default.
- Q95643417 P2093 "Rosemary Huckvale" @default.
- Q95643417 P2093 "Trevor G Smart" @default.
- Q95643417 P304 "108135" @default.
- Q95643417 P31 Q13442814 @default.
- Q95643417 P356 "10.1016/J.NEUROPHARM.2020.108135" @default.
- Q95643417 P577 "2020-05-20T00:00:00Z" @default.
- Q95643417 P698 "32445639" @default.
- Q95643417 P932 "7482436" @default.